{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:53:07Z","timestamp":1765356787754,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41397-020-00192-7","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T22:03:03Z","timestamp":1602021783000},"page":"165-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Characterization of four BCHE mutations associated with prolonged effect of suxamethonium"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9219-1032","authenticated-orcid":false,"given":"Xavier","family":"Brazzolotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Courcelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Sauvanet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Guillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Igert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kononchik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0293-2429","authenticated-orcid":false,"given":"Florian","family":"Nachon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1417-4111","authenticated-orcid":false,"given":"Franck","family":"Ceppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1150-0209","authenticated-orcid":false,"given":"Herv\u00e9","family":"Delacour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"192_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","volume":"148","author":"O Lockridge","year":"2015","unstructured":"Lockridge O. Review of human butyrylcholinesterase structure, function,genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther. 2015;148:34\u201346.","journal-title":"Pharmacol Ther"},{"key":"192_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ygcen.2015.05.017","volume":"224","author":"LM Schopfer","year":"2015","unstructured":"Schopfer LM, Lockridge O, Brimijoin S. Pure human butyrylcholinesterase hydrolyzes octanoyl ghrelin to desacyl ghrelin. Gen Comp Endocrinol. 2015;224:61\u20138.","journal-title":"Gen Comp Endocrinol"},{"key":"192_CR3","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1073\/pnas.1421536112","volume":"112","author":"VP Chen","year":"2015","unstructured":"Chen VP, Gao Y, Geng L, Parks RJ, Pang YP, Brimijoin S. Plasma butyrylcholinesterase regulates ghrelin to control aggression. Proc Natl Acad Sci USA. 2015;112:2251\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"192_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cbi.2016.02.013","volume":"259","author":"S Brimijoin","year":"2016","unstructured":"Brimijoin S, Chen VP, Pang YP, Geng L, Gao Y. Physiological roles for butyrylcholinesterase: a BChE-ghrelin axis. Chem Biol Interact. 2016;259:271\u20135.","journal-title":"Chem Biol Interact"},{"key":"192_CR5","first-page":"1067","volume":"265","author":"A Forbat","year":"1953","unstructured":"Forbat A, Lehmann H, Silk E. Prolonged apnoea following injection of succinylcholine. Lancet. 1953;265:1067\u20138.","journal-title":"Lancet."},{"key":"192_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1139\/y57-041","volume":"35","author":"W Kalow","year":"1957","unstructured":"Kalow W, Genest K. A method for the detection of atypical forms of human serum cholinesterase; determination of dicucaine number. Can J Biochem Physiol. 1957;35:339\u201346.","journal-title":"Can J Biochem Physiol"},{"key":"192_CR7","first-page":"99","volume":"3","author":"H Delacour","year":"2017","unstructured":"Delacour H, Ceppa F. D\u00e9ficit en butyrylcholinest\u00e9rase: quelle d\u00e9marche diagnostique, quelles cons\u00e9quences pour le patient? Anest Reanim. 2017;3:99\u2013100.","journal-title":"Anest Reanim"},{"key":"192_CR8","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1021\/bi962484a","volume":"36","author":"P Masson","year":"1997","unstructured":"Masson P, Legrand P, Bartels CF, Froment MT, Schopfer LM, Lockridge O. Role of aspartate 70 and tryptophan 82 in binding of succinyldithiocholine to human butyrylcholinesterase. Biochemistry. 1997;36:2266\u201377.","journal-title":"Biochemistry."},{"key":"192_CR9","doi-asserted-by":"publisher","first-page":"17170","DOI":"10.1074\/jbc.M109.004952","volume":"284","author":"E Podoly","year":"2009","unstructured":"Podoly E, Shalev DE, Shenhar-Tsarfaty S, Bennett ER, Ben Assayag E, Wilgus H, et al. The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology. J Biol Chem. 2009;284:17170\u20139.","journal-title":"J Biol Chem"},{"key":"192_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cbi.2012.10.010","volume":"203","author":"SM David","year":"2013","unstructured":"David SM, Venkatesan SK, Boopathy R. An Indian butyrylcholinesterase variant L307P is not structurally stable: a molecular dynamics simulation study. Chem Biol Interact. 2013;203:30\u20135.","journal-title":"Chem Biol Interact"},{"key":"192_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.bcp.2014.09.014","volume":"92","author":"H Delacour","year":"2014","unstructured":"Delacour H, Lushchekina S, Mabboux I, Ceppa F, Masson P, Schopfer LM, et al. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), \u201csilent\u201d with mivacurium. Biochem Pharmacol. 2014;92:476\u201383.","journal-title":"Biochem Pharmacol"},{"key":"192_CR12","doi-asserted-by":"publisher","first-page":"e101552","DOI":"10.1371\/journal.pone.0101552","volume":"9","author":"H Delacour","year":"2014","unstructured":"Delacour H, Lushchekina S, Mabboux I, Bousquet A, Ceppa F, Schopfer LM, et al. Characterization of a novel BCHE \u201csilent\u201d allele: pointmutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium. PLoS ONE. 2014;9:e101552.","journal-title":"PLoS ONE"},{"key":"192_CR13","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.3233\/JRS-150699","volume":"27","author":"S Lushchekina","year":"2015","unstructured":"Lushchekina S, Delacour H, Lockridge O, Masson P. Human butyrylcholinesterase polymorphism: Molecular modeling. Int J Risk Saf Med. 2015;27:S80\u20131.","journal-title":"Int J Risk Saf Med"},{"key":"192_CR14","doi-asserted-by":"publisher","first-page":"12074","DOI":"10.1021\/bi00096a018","volume":"32","author":"Z Radic","year":"1993","unstructured":"Radic Z, Pickering NA, Vellom DC, Camp S, Taylor P. Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors. Biochemistry. 1993;32:12074\u201384.","journal-title":"Biochemistry."},{"key":"192_CR15","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1046\/j.0014-2956.2001.02692.x","volume":"269","author":"F Nachon","year":"2002","unstructured":"Nachon F, Nicolet Y, Viguie N, Masson P, Fontecilla-Camps JC, Lockridge O. Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization. Eur J Biochem. 2002;269:630\u20137.","journal-title":"Eur J Biochem"},{"key":"192_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248\u20139.","journal-title":"Nat Methods"},{"key":"192_CR17","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","volume":"31","author":"Y Choi","year":"2015","unstructured":"Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31:2745\u201347.","journal-title":"Bioinformatics."},{"key":"192_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/12.3.219","volume":"12","author":"MJ Karnovsky","year":"1964","unstructured":"Karnovsky MJ, Roots LA. \u201cDirect-coloring\u201d thiocholine method for cholinesterases. J Histochem Cytochem. 1964;12:219\u201321.","journal-title":"J Histochem Cytochem"},{"key":"192_CR19","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.1093\/nar\/gnh172","volume":"32","author":"J Chiu","year":"2004","unstructured":"Chiu J, March PE, Lee R, Tillett D. Site-directed, Ligase-Independent Mutagenesis (SLIM): a single-tube methodology approaching 100% efficiency in 4 h. Nucleic Acids Res. 2004;32:e174.","journal-title":"Nucleic Acids Res"},{"key":"192_CR20","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1021\/bi961412g","volume":"36","author":"O Lockridge","year":"1997","unstructured":"Lockridge O, Blong RM, Masson P, Froment MT, Millard CB, Broomfield CA. A single amino acid substitution, Gly117His, confers phosphotriesterase (organophosphorus acid anhydride hydrolase) activity on human butyrylcholinesterase. Biochemistry. 1997;36:786\u201395.","journal-title":"Biochemistry."},{"key":"192_CR21","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1111\/j.1742-4658.2012.08672.x","volume":"279","author":"X Brazzolotto","year":"2012","unstructured":"Brazzolotto X, Wandhammer M, Ronco C, Trovaslet M, Jean L, Lockridge O, et al. Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure. FEBS J. 2012;279:2905\u201316.","journal-title":"FEBS J"},{"key":"192_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-0366-5_1","volume":"1137","author":"B Webb","year":"2014","unstructured":"Webb B, Sali A. Protein structure modeling with MODELLER. Methods Mol Biol. 2014;1137:1\u201315.","journal-title":"Methods Mol Biol"},{"key":"192_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1\u20132:19\u201325.","journal-title":"SoftwareX"},{"key":"192_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/prot.21123","volume":"65","author":"V Hornak","year":"2006","unstructured":"Hornak V, Abel R, Okur A, Strockbine B, Roitberg A, Simmerling C. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins. 2006;65:712\u201325.","journal-title":"Proteins."},{"key":"192_CR25","doi-asserted-by":"publisher","first-page":"41141","DOI":"10.1074\/jbc.M210241200","volume":"278","author":"Y Nicolet","year":"2003","unstructured":"Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, Nachon F. Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J Biol Chem. 2003;278:41141\u20137.","journal-title":"J Biol Chem"},{"key":"192_CR26","doi-asserted-by":"publisher","first-page":"13270","DOI":"10.1073\/pnas.1817009115","volume":"115","author":"MR Leung","year":"2018","unstructured":"Leung MR, van Bezouwen LS, Schopfer LM, Sussman JL, Silman I, Lockridge O, et al. Cryo-EM structure of the native butyrylcholinesterase tetramer reveals a dimer of dimers stabilized by a superhelical assembly. Proc Natl Acad Sci USA. 2018;115:13270\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"192_CR27","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2174\/092986609789071207","volume":"16","author":"P Masson","year":"2009","unstructured":"Masson P, Carletti E, Nachon F. Structure, activities and biomedical applications of human butyrylcholinesterase. Protein Pept Lett. 2009;16:1215\u201324.","journal-title":"Protein Pept Lett"},{"key":"192_CR28","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1373\/49.8.1297","volume":"49","author":"T Yen","year":"2003","unstructured":"Yen T, Nightingale BN, Burns JC, Sullivan DR, Stewart PM. Butyrylcholinesterase (BCHE) genotyping for post-succinylcholine apnea in an Australian population. Clin Chem. 2003;49:1297\u2013308.","journal-title":"Clin Chem"},{"key":"192_CR29","unstructured":"Karczewski K, Francioli L, Tiao G, Cummings B. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. 2019. https:\/\/www.biorxiv.org\/content\/10.1101\/531210v4."},{"key":"192_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1432-1033.1996.00036.x","volume":"235","author":"P Masson","year":"1996","unstructured":"Masson P, Froment MT, Bartels CF, Lockridge O. Asp70 in the peripheral anionic site of human butyrylcholinesterase. Eur J Biochem. 1996;235:36\u201348.","journal-title":"Eur J Biochem"},{"key":"192_CR31","doi-asserted-by":"publisher","first-page":"9667","DOI":"10.1074\/jbc.M510262200","volume":"281","author":"A De Jaco","year":"2006","unstructured":"De Jaco A, Comoletti D, Kovarik Z, Gaietta G, Radic Z, Lockridge O, et al. A mutation linked with autism reveals a common mechanism of endoplasmic reticulum retention for the alpha,beta-hydrolase fold protein family. J Biol Chem. 2006;281:9667\u201376.","journal-title":"J Biol Chem"},{"key":"192_CR32","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1093\/hmg\/ddu019","volume":"23","author":"X Zhang","year":"2014","unstructured":"Zhang X, Lin H, Zhao H, Hao Y, Mort M, Cooper DN, et al. Impact of human pathogenic micro-insertions and micro-deletions on post-transcriptional regulation. Hum Mol Genet. 2014;23:3024\u201334.","journal-title":"Hum Mol Genet"},{"key":"192_CR33","doi-asserted-by":"crossref","unstructured":"The Uniprot Consortium. Uniprot: a worldwild hub of protein knowledge. Nucleic Acid Res. 2019;47:D506\u201315.","DOI":"10.1093\/nar\/gky1049"},{"key":"192_CR34","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/01.fpc.0000236333.49422.86","volume":"17","author":"LR Mikami","year":"2007","unstructured":"Mikami LR, Wieseler S, Souza RL, Schopfer LM, Lockridge O, Chautard-Freire-Maia EA. Expression of three naturally occurring genetic variants (G75R, E90D, I99M) of the BCHE gene of human butyrylcholinesterase. Pharmacogenet Genom. 2007;17:681\u20135.","journal-title":"Pharmacogenet Genom"},{"key":"192_CR35","first-page":"3r1","volume":"1","author":"LLC Schrodinger","year":"2010","unstructured":"Schrodinger LLC. The PyMOL molecular graphics system. Version. 2010;1:3r1.","journal-title":"Version"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41397-020-00192-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-020-00192-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-020-00192-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T20:54:12Z","timestamp":1633640052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-020-00192-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["192"],"URL":"https:\/\/doi.org\/10.1038\/s41397-020-00192-7","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"type":"print","value":"1470-269X"},{"type":"electronic","value":"1473-1150"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"30 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}